siRNA therapy lowers triglycerides in patients with rare ailment
.RESEARCH FEATURE.19 September 2024.
Plozasiran lessened triglyceride amounts by 80% as well as lowered the danger of pancreatitis in people along with persistent chylomicronemia, along with or even without a hereditary medical diagnosis.